In situ Hybridization Market by Type, Application, End User & by Geography - Analysis and Forecast to 2019

In-situ hybridization (ISH) is a powerful technique used for focusing on specific nucleic acid targets within fixed tissues and cells, to obtain temporal and spatial information about gene expression. The in-situ hybridization technique is divided into two types, namely DNA and RNA. This is because, normally ISH requires isolation of DNA or RNA which is done by separating it on a gel, blotting it onto nitrocellulose, and probing it with a complementary sequence.

The global in-situ hybridization market was valued at $554.4 million 2014, and is estimated to reach $681.0 million by 2019, at a CAGR of 4.2% from 2014 to 2019.

The global in-situ hybridization market is primarily driven by the increasing prevalence of cancer disease, growing usage of personalized medicines for its treatment, and rising number of initiatives undertaken by the government, such as create awareness about cancer and providing funding to support related researches.

The report includes company profiles of major players, recent activities in the market, new product launches, mergers & acquisitions, collaborations and partnerships, and SWOT analysis.

Some of the companies profiled in this report are Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Affymetrix, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and Agilent Technologies, Inc. (U.S.).



Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends, and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging- and high-growth segments of the global in-situ hybridization market, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to analyze the market, which in turn will help the firms in achieving greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:

‧ Product Analysis and development: Detailed insights on upcoming technologies, research and development activities, and new product launches in the global in-situ hybridization market. Usage pattern/ penetration rate (in-depth trend analysis) of products (Segment wise) and purchasing data. Comprehensive coverage of product approvals, pipeline products, and product recalls.
‧ Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for in-situ hybridization across geographies, exploit new distribution channels, new clientele base, and different pricing policies.
‧ Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments decisions in the global in-situ hybridization market. Detailed description regarding the related and unrelated diversification pertaining to this market.
‧ Competitive Assessment: In-depth assessment of market shares, company share analysis of the key players forecasted till 2019. Develop business strategies and manufacturing capabilities of leading players enhance the bottom line of the companies operational in the global in-situ hybridization market.

TABLE OF CONTENTS

1. INTRODUCTION
2. EXECUTIVE SUMMARY
3. MARKET OVERVIEW
4 MARKET DYNAMICS
5 IN-SITU HYBRIDIZATION MARKET, BY TYPE
6 IN-SITU HYBRIDIZATION MARKET, BY APPLICATION
7 IN-SITU HYBRIDIZATION MARKET, BY END USER
8 IN-SITU HYBRIDIZATION MARKET, BY GEOGRAPHY
9 COMPETITIVE LANDSCAPE
10 COMPANY PROFILES
10.1 ABBOTT
10.2 BIOGENEX
10.3 BIOSB
10.4 F. HOFFMANN-LA ROCHE LTD
10.5 SIGMA-ALDRICH CO. LLC.
10.6 ADVANCED CELL DIAGNOSTICS
10.7 AFFYMETRIX, INC.
10.8 EXIQON A/S
10.9 AGILENT TECHNOLOGIES
10.10 THERMO FISHER SCIENTIFIC, INC.
11 APPENDIX